Glenn Sblendorio
Chief Executive Officer chez IVERIC BIO, INC.
Fortune : 984 761 $ au 31/03/2024
Profil
Glenn P.
Sblendorio currently works at IVERIC bio, Inc., as Chief Executive Officer from 2023, Amicus Therapeutics, Inc., as Independent Director from 2006, and Mineralys Therapeutics, Inc., as Independent Director from 2023.
Mr. Sblendorio also formerly worked at Mpm Capital Advisors LLC, as Chief Executive Officer & Managing Director, NuLens Ltd., as Chairman, The Medicines Co., as President, CFO, Treasurer & Director from 2013 to 2016, Intercept Pharmaceuticals, Inc., as Independent Director from 2014 to 2023, Sony Interactive Entertainment LLC, as Managing Director from 1992 to 1996, Amgen, Inc., as Head-Finance & Controller, Oldtech, Inc., as Chief Financial Officer & Executive Vice President from 2002 to 2005, Hoffmann-La Roche, Inc., as Chief Financial Officer, Roche Molecular Systems, Inc., as Chief Financial Officer & Vice President-Finance from 1992 to 1993, and Millennium Venture Management LLC, as Chief Financial Officer.
Mr. Sblendorio received his Masters Business Admin degree in 1985 from Fairleigh Dickinson University and undergraduate degree in 1978 from Pace University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 07/03/2024 | 83 596 ( 0,03% ) | 984 761 $ | 31/03/2024 | |
| 13/09/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Glenn Sblendorio
| Sociétés | Poste | Début |
|---|---|---|
| AMICUS THERAPEUTICS, INC. | Director/Board Member | 01/06/2006 |
| IVERIC BIO, INC. | Chief Executive Officer | 01/07/2017 |
| MINERALYS THERAPEUTICS, INC. | Director/Board Member | 13/09/2023 |
Anciens postes connus de Glenn Sblendorio
| Sociétés | Poste | Fin |
|---|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | Director/Board Member | 08/11/2023 |
| THE MEDICINES COMPANY | Director of Finance/CFO | 01/03/2016 |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Director of Finance/CFO | 01/11/2005 |
Sony Interactive Entertainment LLC
 Sony Interactive Entertainment LLC Packaged SoftwareTechnology Services Sony Interactive Entertainment LLC develops game software. The company was founded on April 1, 2016 and is headquartered in San Mateo, CA. | Corporate Officer/Principal | 01/01/1996 |
Roche Molecular Systems, Inc.
 Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Roche Molecular Systems, Inc. develops and produces molecular-based diagnostic tests and automated testing platforms. It specializes in oncology, virology, microbiology and blood screening tests areas. The firm's customers include researchers, physicians, patients, hospitals, laboratories and blood banks. The company is headquartered in Pleasanton, CA. | Director of Finance/CFO | 01/07/1993 |
Formation de Glenn Sblendorio
| Fairleigh Dickinson University | Masters Business Admin |
| Pace University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| AMGEN INC. | Health Technology |
| AMICUS THERAPEUTICS, INC. | Health Technology |
| INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
| MINERALYS THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 9 |
|---|---|
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Health Technology |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
NuLens Ltd.
 NuLens Ltd. Electronic ComponentsElectronic Technology NuLens Ltd. is engaged in to researching, developing and marketing the novel accommodative Intraocular Lens ('IOL') technology. The Company is focused on exploiting the novel technologies in its patents and developing a real accommodative IOL ('RA-IOL') with the unparalleled capacity of providing over 10 Diopters of accommodative power to the cataract market and a legitimate candidate for the treatment of presbyopia, a vision disorder involving the inability of the eye to focus on near activities such as reading a newspaper or finding a number in a phone book. The company was founded by Joshua Ben-Nun in September 2002 and is headquartered in Herzliya Pituach, Israel. | Electronic Technology |
Roche Molecular Systems, Inc.
Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Roche Molecular Systems, Inc. develops and produces molecular-based diagnostic tests and automated testing platforms. It specializes in oncology, virology, microbiology and blood screening tests areas. The firm's customers include researchers, physicians, patients, hospitals, laboratories and blood banks. The company is headquartered in Pleasanton, CA. | Health Services |
IVERIC bio, Inc.
 IVERIC bio, Inc. Pharmaceuticals: GenericHealth Technology IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ. | Health Technology |
Sony Interactive Entertainment LLC
Sony Interactive Entertainment LLC Packaged SoftwareTechnology Services Sony Interactive Entertainment LLC develops game software. The company was founded on April 1, 2016 and is headquartered in San Mateo, CA. | Technology Services |
| Millennium Venture Management LLC | |
| Mpm Capital Advisors LLC |
